Gustavo Stolovitsky is Program Director of Translational Systems Biology and Nanobiotechnology at IBM Research. In this podcast, he tells us about his career and some of the innovative technologies he is helping to develop, including a Lab-on-a-Chip device to detect cancer.
Lab-on-a-Chip to Help Detect Cancer
News Oct 26, 2016
For 25 years, the AIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now, Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium.READ MORE
Cancer driver genes are those with mutations that are essential for tumour development and spread. Scientists from the Structural Bioinformatics and Network Biology (SBNB) Laboratory at IRB Barcelona have developed a computational pipeline that predicts tumour response to different cancer treatments.READ MORE
Patients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers and, in many cases, resistant to lifesaving drugs. Scientists at The University of Texas at Austin and Ajou University in South Korea have identified a driver of the drug resistance that can make a significant difference for patients with these cancers.